Specimen Collection Study Protocol

Completed

Conditions studied: Focus in on Collecting Paired Specimens for Matrix Equivalency

In brief

The specimens collected will be used to evaluate matrix equivalency in an immunoassay in development for the detection of IgG or IgA or IgM antibodies to SARS - CoV2 in human serum. These reagents are for in vitro diagnostic use only.

Key facts

Study ID

NCT04468386

Run by

Biomerica

People needed

47

Starts

2020-07-07

Expected to finish

2021-05-30

Last updated by the study team

2021-11-24

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Aged 21 and older
• Able to read, speak, and understand English
• Must weigh a minimum of 110 pounds
• Willing and able to donate 20 mLs of whole blood via venipuncture. [approximately ˂ 2 tablespoons]
• Willing and able to donate 0.040 mLs of whole blood via fingerstick
• Willing and able to sign the informed consent (self or authorized representative)
• Willing and able to self-collect a nasal swab per the provided instruction shee

You may not qualify if…

• Aged less than 21 years old
• Unable to provide consent.
• Unable to donate blood via venipuncture and fingerstick.
• Unable to self-collect a nasal swab

Where it is running

• Biomerica, Inc. — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.